Levocabastine: action as a topical antihistamine
Levocabastine (brand names Livocab and generics) is a selective H1 antihistamine of the second generation specifically developed for topical application to the eye and nose. It is used in Germany as eye drops and nasal spray for allergic conjunctivitis and allergic rhinitis. Levocabastine is freely available and can be obtained at pharmacies without a prescription. Topical application offers rapid and targeted onset of action directly at the affected mucous membrane area, with minimal systemic side effects.
Compared to oral antihistamines, levocabastine has the advantage that its effect is very local and rapid, without triggering systemic histamine blockade throughout the body. This makes it a suitable option for patients who have only local symptoms or who wish to avoid oral antihistamines due to sedating side effects or interactions. Levocabastine can also be used in combination with oral antihistamines when topical symptoms are insufficiently controlled.
Mechanism of action
Levocabastine selectively and competitively blocks H1 histamine receptors on the conjunctiva and nasal mucosa. Histamine is a mediator released from mast cells during allergic reactions and triggers symptoms such as itching, sneezing, tears, nasal congestion, and mucosal swelling via H1 receptors. By selectively blocking these receptors, histamine effects are prevented. An anti-inflammatory component is added through reduction of mast cell activation and eosinophil migration.
Onset of action after local application occurs very rapidly, within 5 to 15 minutes. The duration of action is 6 to 12 hours. These properties distinguish levocabastine from mast cell stabilizers such as cromoglycic acid, which require a longer onset time but act preventively. Levocabastine is primarily symptomatic and acts after allergen exposure has already occurred.
Pharmacokinetically, minimal systemic absorption is observed after local application. The plasma concentration after therapeutic use is significantly lower than oral antihistamines and does not lead to sedating effects. The elimination half-life after systemic absorption is approximately 33 to 40 hours; the active substance is 70 percent excreted renally unchanged.
Applications
- Seasonal allergic conjunctivitis, such as in hay fever, pollen allergy, animal dander allergy with eye symptoms
- Perennial allergic conjunctivitis, that is year-round allergic eye irritation from house dust mites or animal hair
- Seasonal allergic rhinitis (hay fever) with nasal symptoms such as sneezing, nasal congestion, itching
- Perennial allergic rhinitis with persistent symptoms from indoor allergens
- Acute allergic reactions of the eyes or nose as on-demand therapy with allergen contact
In patients with concomitant symptoms such as asthma or pronounced systemic allergic reactions, levocabastine can be used as an add-on to systemic therapy, but is not suitable for monotherapy of severe forms.
Dosage and use
Eye drops adults and children from 12 years: one drop of levocabastine 0.5 mg per ml in each affected eye 2 times daily, if necessary up to 4 times daily. Duration of use depends on symptom duration, usually the allergy season.
Eye drops children 6 to 11 years: one drop 2 times daily, medical supervision recommended.
Nasal spray adults and children from 12 years: 2 sprays in each nostril 2 times daily, if necessary up to 4 times daily. Duration of use based on symptoms.
Nasal spray children 9 to 11 years: 2 sprays in each nostril 2 times daily, medical supervision.
Application of eye drops: tilt head back, gently pull down lower eyelid, instill drops into the conjunctival sac without touching the eye. Close eyes, briefly press the tear duct. Remove contact lenses beforehand; reinsert at the earliest 15 minutes after application.
Application of nasal spray: shake bottle before each use. Blow nose clean. Deliver sprays alternately into both nostrils while gently inhaling.
Renal insufficiency: with severe impairment exercise caution and consider dose reduction, as the active substance is predominantly excreted renally. Hepatic insufficiency: adjustment generally not required.
Side effects
Common: local stinging, mild irritation at the site of application, transient blurred vision immediately after application of eye drops, taste disturbances after nasal spray (due to drainage into the throat).
Occasional: eye pain, eyelid swelling, conjunctivitis, fatigue, headache, dizziness.
Rare: shortness of breath, rash, urticaria, allergic reactions including anaphylaxis (very rare).
With nasal spray: nasal dryness, nosebleed (rarely), bitter taste.
Note: Levocabastine is generally considered well tolerated because systemic uptake is minimal with topical application. Sedating effects are rare, significantly less pronounced than with first-generation oral antihistamines.
Drug interactions
- Other antihistamines: with simultaneous systemic antihistamine therapy additive effect. Combination is possible, medical consultation recommended.
- Other eye drops: maintain a minimum interval of 15 minutes from application of other eye drops to avoid dilution effects.
- Vasoconstrictive nasal sprays (oxymetazoline, xylometazoline): combined use possible, however not for continuous use due to rebound risk with vasoconstrictors.
- Topical glucocorticoids: combination useful with more pronounced symptoms, medical guidance.
- Mast cell stabilizers (cromoglycic acid, lodoxamide): synergistic effect possible.
- Contact lenses: remove before application of eye drops, reinsert at the earliest after 15 minutes.
Special notes
Pregnancy: limited data, topical use at usual dosage appears compatible with low risk. Strict indication, medical consultation. Breastfeeding: transfer into breast milk unclear, however considered well tolerated due to minimal systemic absorption.
Children: Levocabastine eye drops from 6 years, nasal spray from 9 years. Use in younger children only after medical evaluation.
Contraindications: known hypersensitivity to levocabastine or other ingredients.
Before use: medical clarification of allergic symptoms, especially with unclear diagnosis or lack of effect.
During therapy: with worsening of symptoms, occurrence of vision impairment, eye pain or other unusual symptoms, medical examination.
Lifestyle: allergen avoidance if possible, avoid known allergen, regular ventilation during low-pollen hours, nasal saline rinse to flush out allergens.
Driving ability: not impaired with normal use. Immediately after eye drops, vision may be briefly blurred, therefore allow a 5 to 10 minute pause before driving.
You may also be interested in
- Cromoglycic acid, mast cell stabilizer as eye and nose medication
- Cetirizine, oral H1 antihistamine
- Loratadine, oral H1 antihistamine of the second generation
- Azelastine, antihistamine as nasal spray and eye drops
- Mometasone, topical glucocorticoid nasal spray
Frequently asked questions
When should I take levocabastine instead of a tablet?
Levocabastine as eye drops or nasal spray is useful when allergic symptoms are primarily local to the eyes or nose. Advantages are rapid local onset of action and no sedation. For systemic symptoms such as skin itching, rash or asthma, oral therapy is necessary. Both can also be combined.
Can I use levocabastine eye drops with contact lenses?
Before application of eye drops, soft contact lenses should be removed because preservatives in the drops can damage the lenses. At the earliest 15 minutes after instillation, the lenses can be reinserted. With hard lenses, use is usually possible with a short pause, medical consultation.
How quickly does levocabastine work?
After local application, levocabastine works within 5 to 15 minutes. This rapid effect makes the active substance suitable for on-demand therapy for acute allergic symptoms. The duration of action is 6 to 12 hours. For chronic symptoms, regular use 2 to 4 times daily is advisable.
Does levocabastine cause drowsiness like other antihistamines?
With topical application as eye drops or nasal spray, systemic uptake is so minimal that no relevant drowsiness occurs. This distinguishes levocabastine clearly from oral antihistamines of the first generation such as diphenhydramine. In very sensitive individuals, mild drowsiness or headache may occasionally occur.
Sources
- Gelbe Liste, Levocabastine active ingredient profile
- BfArM, Federal Institute for Drugs and Medical Devices
- German Society for Allergology and Clinical Immunology (DGAKI)
- AWMF guidelines for allergic rhinitis and conjunctivitis
Legal notes and disclaimer
The information provided on this page is for general information purposes only and does not constitute medical advice, diagnosis, or treatment recommendation. It does not replace the advice of a licensed physician or pharmacist. All information is based on expert information and recognized scientific sources published at the time of creation; the current package insert of the manufacturer is always decisive. Sanoliste assumes no liability for completeness, accuracy, or timeliness of the information presented. In case of a medical emergency, call the emergency number 112.